<code id='23DB4F399B'></code><style id='23DB4F399B'></style>
    • <acronym id='23DB4F399B'></acronym>
      <center id='23DB4F399B'><center id='23DB4F399B'><tfoot id='23DB4F399B'></tfoot></center><abbr id='23DB4F399B'><dir id='23DB4F399B'><tfoot id='23DB4F399B'></tfoot><noframes id='23DB4F399B'>

    • <optgroup id='23DB4F399B'><strike id='23DB4F399B'><sup id='23DB4F399B'></sup></strike><code id='23DB4F399B'></code></optgroup>
        1. <b id='23DB4F399B'><label id='23DB4F399B'><select id='23DB4F399B'><dt id='23DB4F399B'><span id='23DB4F399B'></span></dt></select></label></b><u id='23DB4F399B'></u>
          <i id='23DB4F399B'><strike id='23DB4F399B'><tt id='23DB4F399B'><pre id='23DB4F399B'></pre></tt></strike></i>

          leisure time

          leisure time

          author:hotspot    Page View:4365
          Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT
          Darron Cummings/AP

          The Food and Drug Administration on Thursday approved an Eli Lilly drug that takes a new approach to treating ulcerative colitis, a chronic inflammatory disease that can cause intense gastrointestinal pain and distress.

          The therapy, dubbed Omvoh, is an antibody that blocks IL-23p19, an immune signaling molecule that plays a key role in sustaining the disease. It’s the first treatment to target this particular pathway in ulcerative colitis. The drug’s approval comes after two late-stage trials found that patients taking Omvoh showed a significant improvement in symptoms after both three months and a year compared with those given a placebo, and that the therapy had minimal side effects.

          advertisement

          Omvoh’s list price will be $9,593 per month for intravenous delivery and $10,360 per dose injected beneath the skin. A company spokesperson told STAT that patients who have the drug covered by commercial insurance may pay as little as $5 per month for up to 30 months.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Hollywood unions extend contract negotiations for actors
          Hollywood unions extend contract negotiations for actors

          1:36HollywoodwritersandtheirsupportersfromtheSAGAFTRAactors'unionwalkthepicketlineoutsideWarnerBrosS

          read more
          Chemotherapy drug shortage eases slightly but still widespread
          Chemotherapy drug shortage eases slightly but still widespread

          AdobeTheshortageofcancerdrugsisnotgoingaway,butitmaybeeasingslightly,anewnationalsurveysuggests.Base

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          Why age limits for politicians are a terrible idea

          AdobeArecentpollfromYouGov/CBSNewsshowedthat77%ofrespondentssaidthatthereshouldbeamaximumagelimitfor